author_facet Kraus, Christoph
Seiger, Rene
Pfabigan, Daniela M
Sladky, Ronald
Tik, Martin
Paul, Katharina
Woletz, Michael
Gryglewski, Gregor
Vanicek, Thomas
Komorowski, Arkadiusz
Kasper, Siegfried
Lamm, Claus
Windischberger, Christian
Lanzenberger, Rupert
Kraus, Christoph
Seiger, Rene
Pfabigan, Daniela M
Sladky, Ronald
Tik, Martin
Paul, Katharina
Woletz, Michael
Gryglewski, Gregor
Vanicek, Thomas
Komorowski, Arkadiusz
Kasper, Siegfried
Lamm, Claus
Windischberger, Christian
Lanzenberger, Rupert
author Kraus, Christoph
Seiger, Rene
Pfabigan, Daniela M
Sladky, Ronald
Tik, Martin
Paul, Katharina
Woletz, Michael
Gryglewski, Gregor
Vanicek, Thomas
Komorowski, Arkadiusz
Kasper, Siegfried
Lamm, Claus
Windischberger, Christian
Lanzenberger, Rupert
spellingShingle Kraus, Christoph
Seiger, Rene
Pfabigan, Daniela M
Sladky, Ronald
Tik, Martin
Paul, Katharina
Woletz, Michael
Gryglewski, Gregor
Vanicek, Thomas
Komorowski, Arkadiusz
Kasper, Siegfried
Lamm, Claus
Windischberger, Christian
Lanzenberger, Rupert
International Journal of Neuropsychopharmacology
Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
Pharmacology (medical)
Psychiatry and Mental health
Pharmacology
author_sort kraus, christoph
spelling Kraus, Christoph Seiger, Rene Pfabigan, Daniela M Sladky, Ronald Tik, Martin Paul, Katharina Woletz, Michael Gryglewski, Gregor Vanicek, Thomas Komorowski, Arkadiusz Kasper, Siegfried Lamm, Claus Windischberger, Christian Lanzenberger, Rupert 1461-1457 1469-5111 Oxford University Press (OUP) Pharmacology (medical) Psychiatry and Mental health Pharmacology http://dx.doi.org/10.1093/ijnp/pyz030 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Studies investigating hippocampal volume changes after treatment with serotonergic antidepressants in patients with major depressive disorder yielded inconsistent results, and effects on hippocampal subfields are unclear.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>To detail treatment effects on total hippocampal and subfield volumes, we conducted an open-label study with escitalopram followed by venlafaxine upon nonresponse in 20 unmedicated patients with major depressive disorder. Before and after 12 weeks treatment, we measured total hippocampal formation volumes and subfield volumes with ultra-high field (7 Tesla), T1-weighted, structural magnetic resonance imaging, and FreeSurfer. Twenty-eight remitted patients and 22 healthy subjects were included as controls. We hypothesized to detect increased volumes after treatment in major depressive disorder.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We did not detect treatment-related changes of total hippocampal or subfield volumes in patients with major depressive disorder. Secondary results indicated that the control group of untreated, stable remitted patients, compared with healthy controls, had larger volumes of the right hippocampal-amygdaloid transition area and right fissure at both measurement time points. Depressed patients exhibited larger volumes of the right subiculum compared with healthy controls at MRI-2. Exploratory data analyses indicated lower baseline volumes in the subgroup of remitting (n = 10) vs nonremitting (n = 10) acute patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The results demonstrate that monoaminergic antidepressant treatment in major depressive disorder patients was not associated with volume changes in hippocampal subfields. Studies with larger sample sizes to detect smaller effects as well as other imaging modalities are needed to further assess the impact of antidepressant treatment on hippocampal subfields.</jats:p></jats:sec> Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study International Journal of Neuropsychopharmacology
doi_str_mv 10.1093/ijnp/pyz030
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
Medizin
Psychologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9pam5wL3B5ejAzMA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9pam5wL3B5ejAzMA
institution DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
imprint Oxford University Press (OUP), 2019
imprint_str_mv Oxford University Press (OUP), 2019
issn 1461-1457
1469-5111
issn_str_mv 1461-1457
1469-5111
language English
mega_collection Oxford University Press (OUP) (CrossRef)
match_str kraus2019hippocampalsubfieldsinacuteandremitteddepressionanultrahighfieldmagneticresonanceimagingstudy
publishDateSort 2019
publisher Oxford University Press (OUP)
recordtype ai
record_format ai
series International Journal of Neuropsychopharmacology
source_id 49
title Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_unstemmed Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_full Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_fullStr Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_full_unstemmed Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_short Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_sort hippocampal subfields in acute and remitted depression—an ultra-high field magnetic resonance imaging study
topic Pharmacology (medical)
Psychiatry and Mental health
Pharmacology
url http://dx.doi.org/10.1093/ijnp/pyz030
publishDate 2019
physical 513-522
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Studies investigating hippocampal volume changes after treatment with serotonergic antidepressants in patients with major depressive disorder yielded inconsistent results, and effects on hippocampal subfields are unclear.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>To detail treatment effects on total hippocampal and subfield volumes, we conducted an open-label study with escitalopram followed by venlafaxine upon nonresponse in 20 unmedicated patients with major depressive disorder. Before and after 12 weeks treatment, we measured total hippocampal formation volumes and subfield volumes with ultra-high field (7 Tesla), T1-weighted, structural magnetic resonance imaging, and FreeSurfer. Twenty-eight remitted patients and 22 healthy subjects were included as controls. We hypothesized to detect increased volumes after treatment in major depressive disorder.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We did not detect treatment-related changes of total hippocampal or subfield volumes in patients with major depressive disorder. Secondary results indicated that the control group of untreated, stable remitted patients, compared with healthy controls, had larger volumes of the right hippocampal-amygdaloid transition area and right fissure at both measurement time points. Depressed patients exhibited larger volumes of the right subiculum compared with healthy controls at MRI-2. Exploratory data analyses indicated lower baseline volumes in the subgroup of remitting (n = 10) vs nonremitting (n = 10) acute patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The results demonstrate that monoaminergic antidepressant treatment in major depressive disorder patients was not associated with volume changes in hippocampal subfields. Studies with larger sample sizes to detect smaller effects as well as other imaging modalities are needed to further assess the impact of antidepressant treatment on hippocampal subfields.</jats:p></jats:sec>
container_issue 8
container_start_page 513
container_title International Journal of Neuropsychopharmacology
container_volume 22
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792344996179869699
geogr_code not assigned
last_indexed 2024-03-01T17:16:28.141Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Hippocampal+Subfields+in+Acute+and+Remitted+Depression%E2%80%94an+Ultra-High+Field+Magnetic+Resonance+Imaging+Study&rft.date=2019-08-01&genre=article&issn=1469-5111&volume=22&issue=8&spage=513&epage=522&pages=513-522&jtitle=International+Journal+of+Neuropsychopharmacology&atitle=Hippocampal+Subfields+in+Acute+and+Remitted+Depression%E2%80%94an+Ultra-High+Field+Magnetic+Resonance+Imaging+Study&aulast=Lanzenberger&aufirst=Rupert&rft_id=info%3Adoi%2F10.1093%2Fijnp%2Fpyz030&rft.language%5B0%5D=eng
SOLR
_version_ 1792344996179869699
author Kraus, Christoph, Seiger, Rene, Pfabigan, Daniela M, Sladky, Ronald, Tik, Martin, Paul, Katharina, Woletz, Michael, Gryglewski, Gregor, Vanicek, Thomas, Komorowski, Arkadiusz, Kasper, Siegfried, Lamm, Claus, Windischberger, Christian, Lanzenberger, Rupert
author_facet Kraus, Christoph, Seiger, Rene, Pfabigan, Daniela M, Sladky, Ronald, Tik, Martin, Paul, Katharina, Woletz, Michael, Gryglewski, Gregor, Vanicek, Thomas, Komorowski, Arkadiusz, Kasper, Siegfried, Lamm, Claus, Windischberger, Christian, Lanzenberger, Rupert, Kraus, Christoph, Seiger, Rene, Pfabigan, Daniela M, Sladky, Ronald, Tik, Martin, Paul, Katharina, Woletz, Michael, Gryglewski, Gregor, Vanicek, Thomas, Komorowski, Arkadiusz, Kasper, Siegfried, Lamm, Claus, Windischberger, Christian, Lanzenberger, Rupert
author_sort kraus, christoph
container_issue 8
container_start_page 513
container_title International Journal of Neuropsychopharmacology
container_volume 22
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Studies investigating hippocampal volume changes after treatment with serotonergic antidepressants in patients with major depressive disorder yielded inconsistent results, and effects on hippocampal subfields are unclear.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>To detail treatment effects on total hippocampal and subfield volumes, we conducted an open-label study with escitalopram followed by venlafaxine upon nonresponse in 20 unmedicated patients with major depressive disorder. Before and after 12 weeks treatment, we measured total hippocampal formation volumes and subfield volumes with ultra-high field (7 Tesla), T1-weighted, structural magnetic resonance imaging, and FreeSurfer. Twenty-eight remitted patients and 22 healthy subjects were included as controls. We hypothesized to detect increased volumes after treatment in major depressive disorder.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We did not detect treatment-related changes of total hippocampal or subfield volumes in patients with major depressive disorder. Secondary results indicated that the control group of untreated, stable remitted patients, compared with healthy controls, had larger volumes of the right hippocampal-amygdaloid transition area and right fissure at both measurement time points. Depressed patients exhibited larger volumes of the right subiculum compared with healthy controls at MRI-2. Exploratory data analyses indicated lower baseline volumes in the subgroup of remitting (n = 10) vs nonremitting (n = 10) acute patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The results demonstrate that monoaminergic antidepressant treatment in major depressive disorder patients was not associated with volume changes in hippocampal subfields. Studies with larger sample sizes to detect smaller effects as well as other imaging modalities are needed to further assess the impact of antidepressant treatment on hippocampal subfields.</jats:p></jats:sec>
doi_str_mv 10.1093/ijnp/pyz030
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie, Medizin, Psychologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9pam5wL3B5ejAzMA
imprint Oxford University Press (OUP), 2019
imprint_str_mv Oxford University Press (OUP), 2019
institution DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3
issn 1461-1457, 1469-5111
issn_str_mv 1461-1457, 1469-5111
language English
last_indexed 2024-03-01T17:16:28.141Z
match_str kraus2019hippocampalsubfieldsinacuteandremitteddepressionanultrahighfieldmagneticresonanceimagingstudy
mega_collection Oxford University Press (OUP) (CrossRef)
physical 513-522
publishDate 2019
publishDateSort 2019
publisher Oxford University Press (OUP)
record_format ai
recordtype ai
series International Journal of Neuropsychopharmacology
source_id 49
spelling Kraus, Christoph Seiger, Rene Pfabigan, Daniela M Sladky, Ronald Tik, Martin Paul, Katharina Woletz, Michael Gryglewski, Gregor Vanicek, Thomas Komorowski, Arkadiusz Kasper, Siegfried Lamm, Claus Windischberger, Christian Lanzenberger, Rupert 1461-1457 1469-5111 Oxford University Press (OUP) Pharmacology (medical) Psychiatry and Mental health Pharmacology http://dx.doi.org/10.1093/ijnp/pyz030 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Studies investigating hippocampal volume changes after treatment with serotonergic antidepressants in patients with major depressive disorder yielded inconsistent results, and effects on hippocampal subfields are unclear.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>To detail treatment effects on total hippocampal and subfield volumes, we conducted an open-label study with escitalopram followed by venlafaxine upon nonresponse in 20 unmedicated patients with major depressive disorder. Before and after 12 weeks treatment, we measured total hippocampal formation volumes and subfield volumes with ultra-high field (7 Tesla), T1-weighted, structural magnetic resonance imaging, and FreeSurfer. Twenty-eight remitted patients and 22 healthy subjects were included as controls. We hypothesized to detect increased volumes after treatment in major depressive disorder.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We did not detect treatment-related changes of total hippocampal or subfield volumes in patients with major depressive disorder. Secondary results indicated that the control group of untreated, stable remitted patients, compared with healthy controls, had larger volumes of the right hippocampal-amygdaloid transition area and right fissure at both measurement time points. Depressed patients exhibited larger volumes of the right subiculum compared with healthy controls at MRI-2. Exploratory data analyses indicated lower baseline volumes in the subgroup of remitting (n = 10) vs nonremitting (n = 10) acute patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The results demonstrate that monoaminergic antidepressant treatment in major depressive disorder patients was not associated with volume changes in hippocampal subfields. Studies with larger sample sizes to detect smaller effects as well as other imaging modalities are needed to further assess the impact of antidepressant treatment on hippocampal subfields.</jats:p></jats:sec> Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study International Journal of Neuropsychopharmacology
spellingShingle Kraus, Christoph, Seiger, Rene, Pfabigan, Daniela M, Sladky, Ronald, Tik, Martin, Paul, Katharina, Woletz, Michael, Gryglewski, Gregor, Vanicek, Thomas, Komorowski, Arkadiusz, Kasper, Siegfried, Lamm, Claus, Windischberger, Christian, Lanzenberger, Rupert, International Journal of Neuropsychopharmacology, Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study, Pharmacology (medical), Psychiatry and Mental health, Pharmacology
title Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_full Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_fullStr Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_full_unstemmed Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_short Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
title_sort hippocampal subfields in acute and remitted depression—an ultra-high field magnetic resonance imaging study
title_unstemmed Hippocampal Subfields in Acute and Remitted Depression—an Ultra-High Field Magnetic Resonance Imaging Study
topic Pharmacology (medical), Psychiatry and Mental health, Pharmacology
url http://dx.doi.org/10.1093/ijnp/pyz030